The role of IL-6 and IL-6 blockade in COVID-19
N Potere, A Batticciotto, A Vecchié… - Expert review of …, 2021 - Taylor & Francis
Introduction Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) induces a
dysregulated hyperinflammatory response. Areas covered Authors review evidence on IL-6 …
dysregulated hyperinflammatory response. Areas covered Authors review evidence on IL-6 …
Immunopathological similarities between COVID-19 and influenza: Investigating the consequences of Co-infection
Abstract Coronavirus disease 2019 (COVID-19) caused by severe acute respiratory
syndrome coronavirus 2 (SARS-CoV-2) has been a global public health emergency since …
syndrome coronavirus 2 (SARS-CoV-2) has been a global public health emergency since …
SARS-CoV-2 engages inflammasome and pyroptosis in human primary monocytes
AC Ferreira, VC Soares… - Cell death …, 2021 - nature.com
Infection by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has been
associated with leukopenia and uncontrolled inflammatory response in critically ill patients …
associated with leukopenia and uncontrolled inflammatory response in critically ill patients …
Role of CCL2/CCR2 axis in the pathogenesis of COVID-19 and possible Treatments: All options on the Table
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is cause of the novel
coronavirus disease (COVID-19). In the last two years, SARS-CoV-2 has infected millions of …
coronavirus disease (COVID-19). In the last two years, SARS-CoV-2 has infected millions of …
Effect of IL‐6, IL‐8/CXCL8, IP‐10/CXCL 10 levels on the severity in COVID 19 infection
Background COVID 19 was first observed in December 2019 and has affected the world
entire. Effective laboratory markers and prognostic indicators are needed to predict the …
entire. Effective laboratory markers and prognostic indicators are needed to predict the …
Reduced expression of autophagy markers and expansion of myeloid-derived suppressor cells correlate with poor T cell response in severe COVID-19 patients
Widespread coronavirus disease (COVID)-19 is causing pneumonia, respiratory and
multiorgan failure in susceptible individuals. Dysregulated immune response marks severe …
multiorgan failure in susceptible individuals. Dysregulated immune response marks severe …
Gut microbiota dysbiosis correlates with abnormal immune response in moderate COVID-19 patients with fever
Y Zhou, X Shi, W Fu, F Xiang, X He… - Journal of …, 2021 - Taylor & Francis
Background Most COVID-19 patients are moderate, and fever is the most common clinical
manifestation and associated with poorer prognosis. Gut microbiota may also play important …
manifestation and associated with poorer prognosis. Gut microbiota may also play important …
Interleukin‑6 signalling as a valuable cornerstone for molecular medicine
M Trovato, S Sciacchitano… - International …, 2021 - spandidos-publications.com
The biological abilities of interleukin‑6 (IL‑6) have been under investigation for nearly 40
years. IL‑6 works through an interaction with the complex peptide IL‑6 receptor (IL‑6R). IL‑6 …
years. IL‑6 works through an interaction with the complex peptide IL‑6 receptor (IL‑6R). IL‑6 …
Age-dependent immune responses in COVID-19-mediated liver injury: focus on cytokines
N Aghamohamadi, F Shahba… - Frontiers in …, 2023 - frontiersin.org
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is potentially pathogenic
and causes severe symptoms; in addition to respiratory syndromes, patients might …
and causes severe symptoms; in addition to respiratory syndromes, patients might …
[HTML][HTML] Effect of IL‐6, IL‐8/CXCL8, IP‐10/CXCL 10 levels on the severity in COVID 19 infection
Background COVID 19 was first observed in December 2019 and has affected the world
entire. Effective laboratory markers and prognostic indicators are needed to predict the …
entire. Effective laboratory markers and prognostic indicators are needed to predict the …